Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-003455-61Phase 4Terminated
Phase 4, randomised, double-blind trial of perindopril and l-leucine in Sarcopenia (4 arms), sponsored by Tayside Medical Science Centre. Primary endpoint: Short Physical Performance Battery score at 12 months. Started Mar 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-003455-61.